Dr. Henry A. McKinnell is an Independent Director at ChemoCentryx, Inc., a Chairman at Moody's Corp. and a Member at Massachusetts Institute of Technology.
He is on the Board of Directors at ChemoCentryx, Inc., Emmaus Medical, Inc., Business-Higher Education Forum, Connecticut Science Center, Pharmaceutical Research & Manufacturers of America, The Business Roundtable, The Food & Drug Law Institute, The Medical Device Manufacturers Association, Congressional Medal of Honor Foundation, Medal of Honor Foundation, The Business Council, The Royal Shakespeare Co., The Trilateral Commission, The Economic Club of New York, The Japan Society, The New York City Police Foundation, Inc. and The New York Public Library. Dr. McKinnell was previously employed as an Independent Director by Federal Street Acquisition Corp., an Independent Director by ViewRay, Inc., a Chairman & Chief Executive Officer by Optimer Pharmaceuticals LLC, a Co-Chairman by Accordia Global Health Foundation, a President by Pfizer Pharmaceuticals, Inc., a Chairman by Health Industry Manufacturers Association, a Vice Chairman by The World Economic Forum USA, Inc., and a Trustee by WEF Foundation.
He also served on the board at EMI, Inc., Angiotech Pharmaceuticals (US), Inc., Exxon Mobil Corp., Pfizer Inc. and John Wiley & Sons, Inc.
He received his undergraduate degree from the University of British Columbia, an MBA from Stanford Graduate School of Business and a doctorate degree from Stanford Graduate School of Business.